Diagnosis and management of primary hyperparathyroidism--a scientific statement from the Department of Bone Metabolism, the Brazilian Society for Endocrinology and Metabolism

Arq Bras Endocrinol Metabol. 2013 Aug;57(6):406-24. doi: 10.1590/s0004-27302013000600002.


Objective: To conduct a literature review on the diagnosis and management of primary hyperparathyroidism including the classical hipercalcemic form as well as the normocalcemic variant.

Materials and methods: This scientific statement was generated by a request from the Brazilian Medical Association (AMB) to the Brazilian Society for Endocrinology as part of its Clinical Practice Guidelines program. Articles were identified by searching in PubMed and Cochrane databases as well as abstracts presented at the Endocrine Society, Brazilian Society for Endocrinology Annual Meetings and the American Society for Bone and Mineral Research Annual Meeting during the last 5 years. Grading quality of evidence and strength of recommendation were adapted from the first report of the Oxford Centre for Evidence-based Medicine. All grades of recommendation, including "D", are based on scientific evidence. The differences between A, B, C and D, are due exclusively to the methods employed in generating evidence.

Conclusion: We present a scientific statement on primary hyperparathyroidism providing the level of evidence and the degree of recommendation regarding causes, clinical presentation as well as surgical and medical treatment.

Publication types

  • Practice Guideline

MeSH terms

  • Animals
  • Evidence-Based Medicine
  • Humans
  • Hypercalcemia / complications
  • Hyperparathyroidism / diagnosis*
  • Hyperparathyroidism / etiology
  • Hyperparathyroidism / surgery
  • Parathyroid Glands / pathology
  • Parathyroid Glands / surgery
  • Parathyroid Hormone / blood
  • Parathyroidectomy / standards*


  • Parathyroid Hormone